Literature DB >> 25324664

Toxic Epidermal Necrolysis in a Patient with HLA-B*5901 Haplotype Caused by Topical and Oral Carbonic Anhydrase Inhibitors.

Minseok Cheon1, Young Bok Lee2, Dong-Soo Yu2, Jin-Wou Kim2.   

Abstract

Entities:  

Year:  2014        PMID： 25324664      PMCID： PMC4198599          DOI： 10.5021/ad.2014.26.5.645

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  4 in total

1.  HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Sae-Hoon Kim; Myunghwa Kim; Kyung Wha Lee; Sang-Heon Kim; Hye-Ryun Kang; Heung-Woo Park; Young-Koo Jee
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

2.  Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Thomas Harr; Lars E French
Journal:  Chem Immunol Allergy       Date:  2012-05-03

3.  Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population.

Authors:  K W Lee; D H Oh; C Lee; S Y Yang
Journal:  Tissue Antigens       Date:  2005-05

Review 4.  The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents.

Authors:  Francesco Mincione; Andrea Scozzafava; Claudiu T Supuran
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.